Mátyás Keltai

25.2k total citations · 6 hit papers
71 papers, 7.0k citations indexed

About

Mátyás Keltai is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, Mátyás Keltai has authored 71 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Cardiology and Cardiovascular Medicine, 22 papers in Surgery and 10 papers in Internal Medicine. Recurrent topics in Mátyás Keltai's work include Atrial Fibrillation Management and Outcomes (20 papers), Antiplatelet Therapy and Cardiovascular Diseases (17 papers) and Acute Myocardial Infarction Research (17 papers). Mátyás Keltai is often cited by papers focused on Atrial Fibrillation Management and Outcomes (20 papers), Antiplatelet Therapy and Cardiovascular Diseases (17 papers) and Acute Myocardial Infarction Research (17 papers). Mátyás Keltai collaborates with scholars based in Hungary, United States and Canada. Mátyás Keltai's co-authors include Salim Yusuf, Andrzej Budaj, Leopoldo Soares Piegas, Lars Wallentin, Sonia S. Anand, Shofiqul Islam, Sumathy Rangarajan, Maria Grazia Franzosi, Feng Zhao and Alexander Parkhomenko and has published in prestigious journals such as The Lancet, JAMA and Circulation.

In The Last Decade

Mátyás Keltai

67 papers receiving 6.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial

2008 1.0k citations Johannes F.E. Mann, Janice Pogue et al. The Lancet profile →
A Calcium Antagonist vs a Non–Calcium Antagonist Hypertension Treatment Strategy for Patients With Coronary Artery Disease

2003 859 citations Carl J. Pepine, Giuseppe Mancia et al. profile →
Risk factors for myocardial infarction in women and men: insights from the INTERHEART study

2008 622 citations Sonia S. Anand, Shofiqul Islam et al. European Heart Journal profile →
Impact of Diabetes on Long-Term Prognosis in Patients With Unstable Angina and Non–Q-Wave Myocardial Infarction

2000 570 citations Salim Yusuf, Feng Zhao et al. Circulation profile →
Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study

2010 436 citations Christopher P. Cannon, Stefan James et al. The Lancet profile →
Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial

2012 422 citations Stefan H. Hohnloser, Ziad Hijazi et al. European Heart Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mátyás Keltai Hungary	30	5.3k	1.8k	1.5k	900	661	71	7.0k
Dayi Hu China	43	4.1k 0.8×	1.5k 0.8×	1.0k 0.7×	905 1.0×	368 0.6×	354	7.0k
Peter Bramlage Germany	44	4.1k 0.8×	1.7k 0.9×	2.1k 1.5×	465 0.5×	398 0.6×	464	7.7k
John Goudevenos Greece	38	3.1k 0.6×	1.6k 0.9×	723 0.5×	416 0.5×	497 0.8×	194	6.3k
Maria Grazia Franzosi Italy	31	5.5k 1.0×	1.8k 1.0×	1.3k 0.9×	1.2k 1.4×	844 1.3×	73	8.6k
Susan J. Zieman United States	35	6.5k 1.2×	2.1k 1.2×	814 0.6×	492 0.5×	1.7k 2.5×	62	9.1k
Sarah Parish United Kingdom	10	3.1k 0.6×	2.6k 1.5×	1.5k 1.1×	359 0.4×	721 1.1×	15	6.4k
Peggy Gao Canada	36	3.1k 0.6×	1.3k 0.7×	744 0.5×	845 0.9×	389 0.6×	70	5.4k
Jaap W. Deckers Netherlands	50	7.4k 1.4×	2.9k 1.7×	990 0.7×	725 0.8×	2.0k 3.0×	201	10.7k
Philip R. Liebson United States	32	8.4k 1.6×	2.1k 1.2×	792 0.5×	490 0.5×	2.1k 3.1×	96	10.1k
Alexander Parkhomenko United States	26	6.4k 1.2×	883 0.5×	878 0.6×	1.6k 1.7×	371 0.6×	83	8.0k

Countries citing papers authored by Mátyás Keltai

Since Specialization

Citations

This map shows the geographic impact of Mátyás Keltai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mátyás Keltai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mátyás Keltai more than expected).

Fields of papers citing papers by Mátyás Keltai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mátyás Keltai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mátyás Keltai. The network helps show where Mátyás Keltai may publish in the future.

Co-authorship network of co-authors of Mátyás Keltai

This figure shows the co-authorship network connecting the top 25 collaborators of Mátyás Keltai. A scholar is included among the top collaborators of Mátyás Keltai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mátyás Keltai. Mátyás Keltai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bassand, Jean‐Pierre, Saverio Virdone, A. John Camm, et al.. (2023). Oral anticoagulation across diabetic subtypes in patients with newly diagnosed atrial fibrillation: A report from the GARFIELD‐AF registry. Diabetes Obesity and Metabolism. 25(10). 3040–3053. 1 indexed citations

Caterina, Raffaele De, Giuseppe Patti, John D. Horowitz, et al.. (2020). Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trial. European Heart Journal - Cardiovascular Pharmacotherapy. 8(3). 227–235. 5 indexed citations

Hijazi, Ziad, Christopher B. Granger, Stefan H. Hohnloser, et al.. (2020). Association of Different Estimates of Renal Function With Cardiovascular Mortality and Bleeding in Atrial Fibrillation. Journal of the American Heart Association. 9(18). e017155–e017155. 5 indexed citations

Andell, Pontus, Stefan James, Christopher P. Cannon, et al.. (2015). TICAGRELOR VERSUS CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROMES AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE: AN ANALYSIS FROM THE PLATELET INHIBITION AND PATIENT OUTCOMES (PLATO) TRIAL. Journal of the American College of Cardiology. 65(10). A114–A114. 1 indexed citations

Flaker, Greg, Renato D. Lópes, Elaine M. Hylek, et al.. (2014). Amiodarone, Anticoagulation, and Clinical Events in Patients With Atrial Fibrillation. Journal of the American College of Cardiology. 64(15). 1541–1550. 81 indexed citations

Bonaca, Marc P., Sabina A. Murphy, Debra L. Miller, et al.. (2014). Patterns of Long‐term Thienopyridine Therapy and Outcomes in Patients With Acute Coronary Syndrome Treated With Coronary Stenting: Observations From the TIMI‐38 Coronary Stent Registry. Clinical Cardiology. 37(5). 293–299. 4 indexed citations

Bahit, M. Cecilia, Renato D. Lópes, Daniel Wojdyla, et al.. (2013). Apixaban in patients with atrial fibrillation and prior coronary artery disease: Insights from the ARISTOTLE trial. International Journal of Cardiology. 170(2). 215–220. 46 indexed citations

Bahit, M. Cecilia, Renato D. Lópes, S. H. Hohnloser, et al.. (2012). Abstract 13026: Apixaban in Patients with Atrial Fibrillation and Prior Coronary Artery Disease: Insights from the ARISTOTLE Trial. Circulation. 126. 2 indexed citations

James, Stefan, Andrzej Budaj, Philip E. Aylward, et al.. (2010). Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function. Circulation. 122(11). 1056–1067. 259 indexed citations

10.

Anand, Sonia S., Shofiqul Islam, Annika Rosengren, et al.. (2008). Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. European Heart Journal. 29(7). 932–940. 622 indexed citations breakdown →

11.

Wiviott, Stephen D., Eugene Braunwald, Carolyn H. McCabe, et al.. (2008). Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial. The Lancet. 371(9621). 1353–1363. 325 indexed citations

12.

Keltai, Mátyás, Marcello Tonelli, Johannes F.E. Mann, et al.. (2007). Renal function and outcomes in acute coronary syndrome: impact of clopidogrel. European Journal of Cardiovascular Prevention & Rehabilitation. 14(2). 312–318. 100 indexed citations

13.

Sabatine, Marc S., David A. Morrow, Gilles Montalescot, et al.. (2005). Angiographic and Clinical Outcomes in Patients Receiving Low-Molecular-Weight Heparin Versus Unfractionated Heparin in ST-Elevation Myocardial Infarction Treated With Fibrinolytics in the CLARITY-TIMI 28 Trial. Circulation. 112(25). 3846–3854. 50 indexed citations

14.

Lewis, Basil S., Shamir R. Mehta, Keith A.A. Fox, et al.. (2005). Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: Further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study. American Heart Journal. 150(6). 1177–1184. 53 indexed citations

15.

Mancia, Giuseppe, Mátyás Keltai, Serap Erdine, et al.. (2004). Risk of adverse cardiovascular outcomes and new diabetes with combination therapy in hypertensive patients with coronary artery disease: the INternational VErapamil SR-Trandolapril STudy (INVEST). European Heart Journal. 25. 423–424.

16.

Piegas, Leopoldo Soares, Marcus Flather, Janice Pogue, et al.. (1999). The Organization to Assess Strategies for Ischemic Syndromes (OASIS) registry in patients with unstable angina. The American Journal of Cardiology. 84(5). 7–12. 13 indexed citations

17.

Habon, Tamás, et al.. (1998). An adult case of kawasaki disease with multiplex coronary aneurysms and0 myocardial infarction: The role of transesophageal echocardiography. Clinical Cardiology. 21(7). 529–532. 8 indexed citations

18.

Lengyel, M, Valentı́n Fuster, Mátyás Keltai, et al.. (1997). Guidelines for Management of Left-Sided Prosthetic Valve Thrombosis: A Role for Thrombolytic Therapy 11These guidelines are the results of a Consensus Conference held during the Symposium on Prosthetic Valve Thrombosis on September 16, 1994, in Budapest, Hungary.. Journal of the American College of Cardiology. 30(6). 1521–1526. 162 indexed citations

19.

Krämer, J, Katalin Rajczy, László Hegyi, et al.. (1994). C4B*Q0 allotype as risk factor for myocardial infarction. BMJ. 309(6950). 313–314. 32 indexed citations

20.

Romics, L, et al.. (1978). [Roentgen anatomy of and serum lipids in the coronary vessels in ischemic heart disease].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 119(15). 895–7.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact